Apogee Therapeutics, Inc. Operating Lease, Liability, Noncurrent
Apogee Therapeutics, Inc. (APGE) had Operating Lease, Liability, Noncurrent of $4.47 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability, Noncurrent $4.47M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $4.91M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $5.34M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $5.77M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $4.47M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $4.91M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $5.34M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $5.77M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $6.82M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $7.84M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $8.60M 10-K · filed 2026-03-02 |
| 2024-09-30 | $9.27M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.40M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $630.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $933.00K 10-K · filed 2025-03-03 |